ADME Toxicology Testing Market Report 2025 (Global Edition)

Global ADME Toxicology Testing Market Report 2025 Market Size Split by Technology (Cell Culture, High Throughput, Molecular Imaging, OMICS Technology), by Application (Systemic Toxicity, Renal Toxicit...

ADME Toxicology Testing Market Report Description

We have various report editions of ADME Toxicology Testing Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

ADME Toxicology Testing Market Insights Video

Competitive Landscape of the ADME Toxicology Testing Market

The major players rapidly evolve with new strategies to attain a competitive edge and capture significant market share. The major Adme Toxicology Testing market participants emphasize expanding creative offerings to serve a large consumer base and gain a competitive benefit.

Top Companies Market Share in ADME Toxicology Testing Industry: (In no particular order of Rank)

• Thermo Fisher Scientific Inc. 
• Promega Corporation.  
• Agilent Technologies Inc. 
• Dassault Systèmes 
• Beckman Coulter Inc. 
• Catalent Inc 
• Charles River Laboratories 
• Eurofins Scientific 
• General Electric 
• Merck KGaA 
• Miltenyi Biotec 
• Bio-Rad Laboratories Inc. 
• BioIVT LLC. 
• Catalent Inc. 
• AbbVie 
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

In terms of revenue, the North American ADME Toxicology Testing Market share was 40% of the total market

According to Cognitive Market Research, North America led the market in 2023 and generated around 40% of worldwide revenue. Market expansion is fueled by the pharmaceutical industry's emphasis on strict adherence to regulations and thorough safety assessments in the region. North America's prominence in toxicity testing is partly due to its advanced technologies and dedication to innovation. The region is positioned to play a significant role in determining the direction of the ADME Toxicology Testing market due to the growing need for accurate Absorption, Distribution, Metabolism, and Excretion (ADME) evaluations in drug development.

Europe is the fastest-growing category as Modern toxicity testing techniques are in high demand since the pharmaceutical and biotechnology industries in the area prioritize safety assessments during the drug development process. Europe is a key region that shapes the ADME Toxicology Testing market landscape, emphasizing technological innovation, regulatory compliance, and developments in drug discovery and safety assessments. 

The current report Scope analyzes ADME Toxicology Testing Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Switzerland, Luxembourg, Rest of Europe)
• Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Taiwan, South East Asia, Rest of APAC)
• Latin America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East (Saudi Arabia, Turkey, UAE, Egypt, Qatar, Rest of Middle East)
• Africa (Nigeria, South Africa, Rest of Africa)

The above graph is for illustrative purposes only.

North America ADME Toxicology Testing Market Analysis

According to Cognitive Market Research, the global Adme Toxicology Testing market size was estimated at USD 8915.2 Million out of which North America held the major market of more than 40% of the global revenue with a market size of USD 3566.08 million in 2023 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2023 to 2030. With a strong pharmaceutical sector and a dedication to strict safety reviews, North America is a major player in the ADME Toxicology Testing market. To guarantee the safety and effectiveness of medications, the area places a strong emphasis on thorough toxicity testing, which includes assessments of Absorption, Distribution, Metabolism, and Excretion (ADME). North America is leading the way in developing the direction of Adme Toxicology Testing with its technological innovations and emphasis on regulatory compliance. The need for accurate safety assessments in the pharmaceutical business places North America at the forefront of the market's development, stimulating creativity and propelling improvements in drug development procedures throughout the industry.

• According to Cognitive Market Research, the US had a major share in the ADME Toxicology Testing market with a market size of USD 2813.64 million in 2023 and is projected to grow at a CAGR of 8.8%% during the forecast period. This is majorly due to its focus on improving drug development procedures. 
• The Canada Adme Toxicology Testing market had a market share of USD 8.8% million in 2023 and is projected to grow at a CAGR of 8.8%% during the forecast period. This is due to the growing demand for safety assessments. 
• The Mexico Adme Toxicology Testing market is projected to witness growth at a CAGR of 9.5% during the forecast period with a market size of USD 324.51 million in 2023.

Europe ADME Toxicology Testing Market Analysis

According to Cognitive Market Research, with a market value of USD 8915.2 million in 2023 and projected to expand at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030, Europe accounted for a share of over 30% of the global market size of USD 2674.56 million. Europe's strong pharmaceutical and biotechnology sectors make it a major player in the ADME Toxicology Testing market. Due to the region's emphasis on safety assessments during the drug development process, there is a significant demand for sophisticated toxicological testing procedures, such as thorough analyses of the processes of absorption, distribution, metabolism, and excretion (ADME). The ADME Toxicology Testing landscape is significantly shaped by European nations, who prioritize technical innovation and regulatory compliance. Due to its strict adherence to safety regulations, Europe is positioned to play a significant role in promoting improvements in safety assessments and advancing the general progress of drug discovery and development procedures in the pharmaceutical and biotech industries.

• According to Cognitive Market Research, the Germany Adme Toxicology Testing market size was valued at USD 529.56 million in 2023 and is projected to grow at a CAGR of 9.5% during the forecast period. This is majorly due to the expanding pharmaceutical industry. 
• The United Kingdom Adme Toxicology Testing market had a market share of USD 449.33 million in 2023 and is projected to grow at a CAGR of 10.1% during the forecast period. This is due to the rising R&D spending. 
• The France ADME Toxicology Testing market is projected to witness growth at a CAGR of 8.5% during the forecast period with a market size of USD 246.06 million in 2023.
• The Italy Adme Toxicology Testing market is projected to witness growth at a CAGR of 8.7% during the forecast period with a market size of USD 230.01 million in 2023.
• The Russia Adme Toxicology Testing market is projected to witness growth at a CAGR of 8.3% during the forecast period with a market size of USD 414.56 million in 2023.
• The Spain Adme Toxicology Testing market is projected to witness growth at a CAGR of 8.4% during the forecast period with a market size of USD 219.31 million in 2023.
• The Portugal ADME Toxicology Testing market is projected to witness growth at a CAGR of 9.1% during the forecast period with a market size of USD 56.17 million in 2023.
• The Luxembourg Adme Toxicology Testing market is projected to witness growth at a CAGR of 9.4% during the forecast period with a market size of USD 82.91 million in 2023.
• The Greece Adme Toxicology Testing market is projected to witness growth at a CAGR of 9.6% during the forecast period with a market size of USD 32.09 million in 2023.
• The Rest of Europe Adme Toxicology Testing market is projected to witness growth at a CAGR of 8.0% during the forecast period with a market size of USD 414.56 million in 2023.

Asia Pacific ADME Toxicology Testing Market Analysis

According to Cognitive Market Research, the global Adme Toxicology Testing market size was estimated at USD 8915.2 Million out of which Asia Pacific held the market of more than 23% of the global revenue with a market size of USD 2050.50 million in 2023 and will grow at a compound annual growth rate (CAGR) of 12.8% from 2023 to 2030. Asia Pacific's thriving pharmaceutical and biotechnology industries propel the region to become a dynamic hub in the ADME Toxicology Testing market. Asia Pacific is seeing an increase in demand for accurate assessments of Absorption, Distribution, Metabolism, and Excretion (ADME), as well as for thorough toxicological testing, due to the region's focus on improving drug development procedures. Asia Pacific's dedication to technological innovation and the growing pharmaceutical industry position the region as a major force shaping the ADME Toxicology Testing market. The region is vital to innovation and the evolution of safety evaluations in drug development across various pharmaceutical and biotech industry segments, especially as it experiences continued industrial growth and research developments.

• According to Cognitive Market Research, the China Adme Toxicology Testing market size was valued at USD 922.72 million in 2023 and is projected to grow at a CAGR of 12.3% during the forecast period. This is majorly due to the growing demand for metabolism, and excretion (ADME). 
• The India Adme Toxicology Testing market had a market share of USD 246.06 million in 2023 and is projected to grow at a CAGR of 14.6% during the forecast period. This is due to the increased demand for extensive testing for absorption. 
• The Japan Adme Toxicology Testing market is projected to witness growth at a CAGR of 11.3% during the forecast period with a market size of USD 282.97 million in 2023.
• The South Korea Adme Toxicology Testing market is projected to witness growth at a CAGR of 11.9% during the forecast period with a market size of USD 205.05 million in 2023.
• The Australia Adme Toxicology Testing market is projected to witness growth at a CAGR of 12.5% during the forecast period with a market size of USD 106.63 million in 2023.
• The South East Asia Adme Toxicology Testing market is projected to witness growth at a CAGR of 13.8% during the forecast period with a market size of USD 141.48 million in 2023.
• The Rest of Asia Pacific Adme Toxicology Testing market is projected to witness growth at a CAGR of 12.6% during the forecast period with a market size of USD 145.59 million in 2023.

South America ADME Toxicology Testing Market Analysis

According to Cognitive Market Research, the global Adme Toxicology Testing market size was estimated at USD 8915.2 Million out of which Latin America market of more than 5% of the global revenue with a market size of USD 445.76 million in 2023 and will grow at a compound annual growth rate (CAGR) of 10.2% from 2023 to 2030. With a developing pharmaceutical and biotechnology industry, Latin America is gaining traction in the ADME Toxicology Testing market. The demand for advanced toxicological testing procedures, particularly in the context of Absorption, Distribution, Metabolism, and Excretion (ADME) assessments, is driven by the region's emphasis on safety evaluations in drug development. Latin America is a major force in the ADME Toxicology Testing market because of its dedication to technical improvements and regulatory compliance. The region's growing pharmaceutical industry makes a substantial contribution to the development of safety evaluations, which in turn promotes innovation and has an impact on the larger landscape of drug discovery and development procedures across different pharmaceutical and biotech industry segments.

• According to Cognitive Market Research, the Brazil Adme Toxicology Testing market size was valued at USD 190.79 million in 2023 and is projected to grow at a CAGR of 10.8% during the forecast period. This is majorly due to the growing demand for need for sophisticated toxicological techniques. 
• The Argentina Adme Toxicology Testing market had a market share of USD 74.89 million in 2023 and is projected to grow at a CAGR of 11.1% during the forecast period. This is due to the increased demand for stringent safety evaluations. 
• The Colombia Adme Toxicology Testing market is projected to witness growth at a CAGR of 10.0% during the forecast period with a market size of USD 39.67 million in 2023.
• The Peru ADME Toxicology Testing market is projected to witness growth at a CAGR of 10.4% during the forecast period with a market size of USD 36.55 million in 2023.
• The Chile ADME Toxicology Testing market is projected to witness growth at a CAGR of 10.5% during the forecast period with a market size of USD 32.09 million in 2023.
• The Rest of the Latin America Adme Toxicology Testing market is projected to witness growth at a CAGR of 9.3% during the forecast period with a market size of USD 71.77 million in 2023.

Middle East ADME Toxicology Testing Market Analysis

According to Cognitive Market Research, the global Adme Toxicology Testing market size was estimated at USD 8915.2 Million out of which Middle East and Africa held the major market of more than 2% of the global revenue with a market size of USD 178.30 million in 2023 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2023 to 2030. Driven by a combination of industrial growth and technical advancements, Middle East & Africa (MEA) is becoming a significant player in the ADME Toxicology Testing market. The need for sophisticated toxicological testing is rising in the area, especially in the biotechnology and pharmaceutical industries where cutting-edge approaches to Absorption, Distribution, Metabolism, and Excretion (ADME) evaluations are critical. MEA is a prominent player in the global Adme Toxicology Testing market because of its dedication to diversifying economies and implementing cutting-edge technology. Despite the market's diversity, the biotech and pharmaceutical sectors stand out as key players in the adoption of cutting-edge testing techniques. MEA is well-positioned to contribute to the advancement of safety assessments in drug development as long as it keeps making investments in technology and healthcare.

• According to Cognitive Market Research, the GCC Countries Adme Toxicology Testing market size was valued at USD 76.31 million in 2023 and is projected to grow at a CAGR of 11.3% during the forecast period. This is majorly due to the growing demand for thriving pharmaceuticals. 
• The South Africa Adme Toxicology Testing market had a market share of USD 28.17 million in 2023 and is projected to grow at a CAGR of 11.518% during the forecast period. This is due to the increased demand for biotechnology sectors. 
• The Egypt Adme Toxicology Testing market is projected to witness growth at a CAGR of 10.8% during the forecast period with a market size of USD 18.72 million in 2023.
• The Turkey Adme Toxicology Testing market is projected to witness growth at a CAGR of 10.0% during the forecast period with a market size of USD 15.33 million in 2023.
• The Nigeria Adme Toxicology Testing market is projected to witness growth at a CAGR of 9.6% during the forecast period with a market size of USD 18.72 million in 2023.
• The Rest of MEA Adme Toxicology Testing market is projected to witness growth at a CAGR of 21.04% during the forecast period with a market size of USD 9.5 million in 2023.

ADME Toxicology Testing Market Analysis

ADME Toxicology Testing Technology Segment Analysis

According to Cognitive Market Research, Cell Culture holds a prominent market share. Cell culture techniques offer a platform for assessing drug Absorption, Distribution, Metabolism, and Excretion (ADME) by utilizing cell-based tests. This method provides important insights into the safety and effectiveness of chemicals, improving the accuracy and predictability of toxicological testing and advancing the market's pharmaceutical, biotechnology, and research sectors.

Molecular Imaging is the fastest-growing category over the forecast period. These methods offer real-time insights into drugs' absorption, Distribution, Metabolism, and Excretion (ADME) by utilizing cutting-edge molecular imaging technology. Molecular Imaging contributes to the growth of the pharmaceutical, biotechnology, and research sectors by improving the accuracy of toxicological testing and providing a thorough understanding of biological processes.

• Cell Culture
• High Throughput
• Molecular Imaging
• OMICS Technology

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of ADME Toxicology Testing Industry. Request a Free Sample PDF!

ADME Toxicology Testing Application Segment Analysis

According to Cognitive Market Research, Systemic Toxicity holds a prominent market share. In systemic toxicity testing, the harmful effects of chemicals are assessed on the whole organism. This method guarantees a thorough comprehension of possible hazards, directing medication development and safety evaluations. The market for Adme Toxicology Testing is evolving due to the increased focus on systemic toxicity, which improves overall medication safety assessments and conforms to regulatory requirements.

Renal toxicity is the fastest-growing category over the forecast period, 

 Renal toxicity testing, which assesses the effects of chemicals on the kidneys, is essential for thorough safety evaluations in the drug development process. The market for accurate renal toxicity testing has expanded throughout the pharmaceutical, biotechnology, and research sectors due to growing awareness of potential nephrotoxic effects.

• Systemic Toxicity
• Renal Toxicity
• Hepatotoxicity
• Neurotoxicity
• Other Toxicities

The above Graph is for representation purposes only. This chart does not depict actual Market share.

ADME Toxicology Testing Method Segment Analysis

According to Cognitive Market Research, Cellular Assay holds a prominent market. Cellular tests are essential when assessing a substance's Absorption, Distribution, Metabolism, and Excretion (ADME) at the cellular level. Technological developments in cellular assays yield more precise and forecast results, increasing the effectiveness of toxicological testing. Adopting cellular assays offers enhanced capabilities in drug development and safety evaluations across pharmaceutical, biotechnology, and research sectors, contributing to the market's progress.

The Biochemical Assay is the fastest-growing category over the forecast period. Biochemical assays are utilized to assess a substance's absorption, distribution, metabolism, and excretion (ADME) and gain an important understanding of its toxicological consequences. These instruments improve the accuracy and efficacy of toxicological testing thanks to developments in biochemical assay technologies, fuel market growth in the pharmaceutical, biotechnology, and research industries.

• Cellular Assay
• Biochemical Assay
• In-Silica
• Ex-vivo

ADME Toxicology Testing Product Type Segment Analysis

According to Cognitive Market Research, Cellular Assay held the major market share over the forecast period. These assays are essential for assessing a substance's cellular toxicity, metabolism, absorption, and distribution. The efficiency of toxicity testing is increased by improvements in cellular assay technology, which yields more precise and predicted results. Cellular assays are becoming more widely used, helping the pharmaceutical, biotechnology, and research sectors enhance their capacities for drug development and safety evaluations.

Biochemical Assay is the fastest-growing category over the forecast period. When assessing a substance's Absorption, Distribution, Metabolism, and Excretion (ADME), biochemical assays are crucial in revealing important information about its toxicological consequences. The pharmaceutical, biotechnology, and research sectors have seen growth in the market for these instruments, which improve the accuracy and efficacy of toxicological testing through improvements in biochemical assay method

• Instruments
• Software Solutions
• Assays Systems
• Reagents
• Others

ADME Toxicology Testing End-users Segment Analysis

Cognitive Market Research shows Cosmetics and Household Products hold a prominent market share. Given the increased emphasis on product safety, thorough toxicological testing is essential to guaranteeing no unfavorable impacts. The need for precise evaluations of Absorption, Distribution, Metabolism, and Excretion (ADME) in home goods and cosmetics supports the expansion of the industry by meeting consumer expectations for safe and efficient personal care products and legal requirements.

The Pharmaceutical Industry is the fastest-growing category over the forecast period. Drug development and safety assessments require extensive testing of drug candidates for Absorption, Distribution, Metabolism, and Excretion (ADME). The pharmaceutical industry's continued emphasis on thorough toxicity evaluations is driving up demand for sophisticated testing procedures, which is propelling the market's growth and promoting improvements in the processes involved in drug research and development.

• Cosmetics and Household Products
• Pharmaceutical Industry
• Animal Industry
• Food Industry
• Others

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion